April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin
April 5, 2019 Muscular Dystrophy Association 2019 Clinical and Scientific Conference Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or
March 19, 2019 The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients
March 18, 2019 Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson’s Disease Romero K, Conrado D, Burton J, Nicholas T, Sinha V, Macha S, Ahamadi M, Cedarbaum J, Seibyl J, Marek K, Basseches P, Hill D...
March 17, 2019 Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA
March 10, 2019 Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
February 23, 2019 Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies
February 19, 2019 Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA
February 8, 2019 Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders
